Add this topic to your myFT Digest for news straight to your inbox
Shadow science minister Chi Onwurah pledges more collaborative approach and greater respect for institutions
Also in this newsletter: ‘seismic’ by-election results for Labour, and G7 at odds over Russia’s frozen assets
While pandemic risk is low, scientists say urgent investigations into the virus are necessary
For stretched public health budgets, high-tech treatments are hard to afford but some pre-emptive measures can prove good value
Caseloads of cancer and other illnesses of ageing are forecast to rise steeply in lower income countries
Wellcome’s John-Arne Røttingen says divisions risk harming action on pandemic responses and ‘superbugs’
‘Sea sparkle’ bedazzles in the dark but is responsible for a reeking green carpet of algae by day
Now is not a time for paranoia but there is a case for extreme vigilance
The FT’s senior science writer tests it out
Damage to habitats and closer contact can help multiple infections jump from wildlife
Environmental change and adaptation risk prompts new research in neglected field
Disease specialists point to shifts in the patterns of mosquito-borne infection
Global warming, flooding and pollution could all help promote evolution of pathogens
Habitat encroachment means more opportunities for animal-to-human infection
Changing climate and human population shifts have spread and strengthened foothold
The craft embodies a golden age of space exploration
Research is finding ways to extend animal lifespans but regulators are still wary of treating ageing as a disease
The FT’s fifth annual ranking of the region’s businesses by revenue growth. Plus: outsourcers tap into remote work boom; Shopify targets more growth from bigger clients; Brazil’s alternative to electric vehicles; and Vertex Pharmaceutical’s potential answer to the opioid crisis
Technique devised for Timothy syndrome could open way to therapies for other untreatable conditions
Technique highlights concerns shifting global disease burden as populations age
High costs and concerns over efficacy and side effects limit uptake of first treatment as another nears approval
Also in this newsletter: IMF warns EU off ‘subsidy race’, Apple under pressure from China, science round-up
Colour is used by architects and designers for many reasons but can the psychology behind it help you sort out your own interior dilemmas?
Deputy PM says government will examine new curbs around technology sharing and call in vice-chancellors
Research harnesses power of generative artificial intelligence in latest sign of its potential use in medicine
International Edition